Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 


CCEDV36N5_Cover_5th.inddVolume 36, Issue 5
Published by AEGIS Communications

Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial

Jack L. Martin, MD; Neil Gottehrer, DDS; Harvey Zalesin, DDS; Paul T. Hoff, MD; Michael Shaw, PhD; James H.W. Clarkson, MD; Pam Haan, BSN; Mark Vartanian; Terry McLeod, BSN; and Stephen M. Swanick